Technical Analysis for IMUC - Immunocellular Thera

Grade Last Price % Change Price Change
grade A 0.0279 -1.06% -0.0003
IMUC closed down 1.06 percent on Friday, August 23, 2019, on 45 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical IMUC trend table...

Date Alert Name Type % Chg
Stochastic Sell Signal Bearish 0.00%
20 DMA Support Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Down 3 Days in a Row Weakness 0.00%
20 DMA Support Bullish -1.06%
NR7 Range Contraction -1.06%

Older signals for IMUC ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, develops immune-based therapies for the treatment of various cancers. Its products include ICT-107, a dendritic cell (DC) immunotherapy for the treatment of diagnosed glioblastoma multiforme (GBM); ICT-140, a DC-based immunotherapy targets tumor associated antigens on ovarian cancer; and ICT-121, a DC-based immunotherapy targeting CD133 markers and CSCs to treat recurrent GBM and other solid tumor cancers. The company is developing Steam-to-T-Cell immunotherapies for the treatment of cancer. It has license agreements with California Institute of Technology and The Johns Hopkins University. The company was formerly known as Optical Molecular Imaging, Inc. and changed its name to ImmunoCellular Therapeutics, Ltd. in November 2006. ImmunoCellular Therapeutics, Ltd. is based in Westlake Village, California.
Medicine Health Biotechnology RTT Cancer Treatment Of Cancer Cancers Immunotherapy Oncology Cancer Immunotherapy Ovarian Cancer Immunotherapies Virotherapy Glioblastoma Brain Tumor Solid Tumor Cancers Northwest Biotherapeutics California Institute Of Technology Glioblastoma Multiforme Steam
Is IMUC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 0.05
52 Week Low 0.012
Average Volume 130,098
200-Day Moving Average 0.0245
50-Day Moving Average 0.0228
20-Day Moving Average 0.0264
10-Day Moving Average 0.027
Average True Range 0.0067
ADX 21.44
+DI 12.4604
-DI 5.7022
Chandelier Exit (Long, 3 ATRs ) 0.0119
Chandelier Exit (Short, 3 ATRs ) 0.0376
Upper Bollinger Band 0.0311
Lower Bollinger Band 0.0217
Percent B (%b) 0.66
BandWidth 35.606061
MACD Line 0.0014
MACD Signal Line 0.0012
MACD Histogram 0.0001
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0323
Resistance 3 (R3) 0.0318 0.0298 0.0315
Resistance 2 (R2) 0.0298 0.0287 0.0301 0.0313
Resistance 1 (R1) 0.0289 0.0280 0.0294 0.0294 0.0310
Pivot Point 0.0269 0.0269 0.0272 0.0272 0.0269
Support 1 (S1) 0.0260 0.0258 0.0265 0.0265 0.0248
Support 2 (S2) 0.0240 0.0251 0.0243 0.0245
Support 3 (S3) 0.0231 0.0240 0.0243
Support 4 (S4) 0.0236